BiotaX Labs Overview
BiotaX has developed deep explainable AI models based on system biology that can collect, analyze, and predict multiple disease states and calculate optimal interventions supported by meta-genomic AI analysis. CustomBiome's live biotherapeutic production technology is able to isolate targeted live microbes on the strain level (TaxonAI Output) based either on their taxonomy or gene functionality. BiotaX can package these microbes as customized live biotherapeutic products to fight dysbiosis in a personalized and disease-specific way.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
An Israeli development will replace one of the most intrusive and frightening examinations with a simple at-home test
The article discusses a new attack on machine learning where an adversary poisons a training set to harm the privacy of other users data. It also mentions that c3 Communications has started its 23rd year in business with 5 new clients. The impact on the company is growth-positive. The key theme of the article is the privacy implications of the new attack on machine learning. The key issue discussed is the potential harm to the privacy of users data. The article does not mention any specific partners, customers, valuation amount, acquisition amount, investment amount, layoffs, or date of the event. The confidence level is 7 out of 10.
Customers
growth-positive
Press Release
Illumina, Inc. has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator. The company has also secured over £20 million in initial UK capital commitments, including a £10 million commitment from cornerstone investor LifeArc. The capital commitments will provide match funding to every Illumina Accelerator Cambridge graduate that secures between £500,000 up to £4 million in qualified new capital. Illumina Accelerator provides selected startups with seed investment, access to Illumina sequencing systems and reagents, business guidance, genomics expertise, and lab space. The newest companies to join Illumina Accelerators portfolio include BiotaX Labs, Broken String Biosciences, Mitra Bio, MultiplAI Health, Doloromics Inc., Flightpath Biosciences, Oshun Medical, Parallel Health, and Rubik Therapeutics. Illumina Accelerator is accepting applications for the next funding cycle.
InvestmentExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 3 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | www.biotax.co/ |
Locations
Givatayim, Israel
Photos & Videos
No files yet
